AlphaStocks
6.6
Consider Buy

QUEST DIAGNOSTICS INC (DGX)

Health Care / Health Care Services

S&P 500

$231.95

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

#137out of 1123 in Health Care

Is QUEST DIAGNOSTICS INC a Good Investment in 2026?

QUEST DIAGNOSTICS INC (DGX) scores 6.6 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates QUEST DIAGNOSTICS INC as Strong (8/9). However, the Graham model rates it Caution — 86% above fair value. QUEST DIAGNOSTICS INC currently trades above its estimated fair value of $200, suggesting limited upside at current prices. QUEST DIAGNOSTICS INC ranks #137 out of 1123 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E26.4ROE13.8Market Cap26BDiv Yield1.5

Estimated Fair Value

$199.5716% above

Trading slightly above estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

86% above fair value

Lynch

Neutral

PEG 3.8 · Stalwart

Greenblatt

Attractive

Top 25% (rank 12%)

Frequently Asked Questions

Is QUEST DIAGNOSTICS INC (DGX) a good investment?
Based on AlphaStocks' composite analysis, QUEST DIAGNOSTICS INC (DGX) scores 6.6 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trading slightly above estimated fair value.
What is QUEST DIAGNOSTICS INC's Piotroski F-Score?
QUEST DIAGNOSTICS INC's Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is DGX overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $200, DGX appears overvalued. The stock currently trades 16% above its estimated fair value. Trading slightly above estimated fair value.
How does DGX compare to other Health Care stocks?
QUEST DIAGNOSTICS INC ranks #137 out of 1123 stocks in the Health Care sector, placing it in the top 12% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about DGX?
AlphaStocks evaluates DGX using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 6.6/10.

Similar Stocks

PARRBFAMNTAP

Compare DGX with

DGX vs PARRDGX vs BFAMDGX vs NTAP

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer